1. Home
  2. AIHS vs VIVS Comparison

AIHS vs VIVS Comparison

Compare AIHS & VIVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AIHS

Senmiao Technology Limited

HOLD

Current Price

$1.40

Market Cap

5.3M

Sector

Finance

ML Signal

HOLD

Logo VivoSim Labs Inc.

VIVS

VivoSim Labs Inc.

BUY

Current Price

$1.89

Market Cap

5.0M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
AIHS
VIVS
Founded
2014
2007
Country
China
United States
Employees
N/A
13
Industry
Finance: Consumer Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.3M
5.0M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
AIHS
VIVS
Price
$1.40
$1.89
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
10.6K
168.5K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
14.63
N/A
EPS
N/A
N/A
Revenue
$3,389,072.00
N/A
Revenue This Year
N/A
$42.38
Revenue Next Year
N/A
$15.42
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.25
$1.42
52 Week High
$8.26
$5.30

Technical Indicators

Market Signals
Indicator
AIHS
VIVS
Relative Strength Index (RSI) 65.87 45.31
Support Level $1.12 $1.75
Resistance Level $1.42 $2.17
Average True Range (ATR) 0.05 0.17
MACD 0.01 -0.01
Stochastic Oscillator 85.74 15.56

Price Performance

Historical Comparison
AIHS
VIVS

About AIHS Senmiao Technology Limited

Senmiao Technology Ltd is a holding company. Along with its subsidiaries, it is engaged in facilitating automobile transactions and offering related services. The group's business activities include providing car rental services to individual customers with lease term no more than twelve months; leasing and servicing of new energy vehicles; offering services to automobile purchasers throughout the purchase process; providing management and related services to Partner Platforms and other companies; automobile financing; and providing other related supporting services to customers. The majority of the group's revenue is generated from its automobile rental business.

About VIVS VivoSim Labs Inc.

VivoSim Labs Inc formerly, Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases. It is now offering liver toxicology predictive screening and research services as well as working on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at all stages of drug development.

Share on Social Networks: